Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
CNY 17.34
(-1.37%)
CNY 17.34
(-1.37%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 868.25 Million CNY | 20.28% |
| 2022 | 721.89 Million CNY | 10.49% |
| 2021 | 653.35 Million CNY | 30.77% |
| 2020 | 499.62 Million CNY | 18.66% |
| 2019 | 421.05 Million CNY | 18.43% |
| 2018 | 355.53 Million CNY | 14.46% |
| 2017 | 310.6 Million CNY | -7.43% |
| 2016 | 335.52 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 286.7 Million CNY | 3.36% |
| 2024 Q2 | 279.64 Million CNY | 10.92% |
| 2024 Q1 | 252.1 Million CNY | 17.55% |
| 2023 Q3 | 241.03 Million CNY | 10.42% |
| 2023 Q1 | 194.47 Million CNY | 13.38% |
| 2023 FY | 868.25 Million CNY | 20.28% |
| 2023 Q2 | 218.28 Million CNY | 12.24% |
| 2023 Q4 | 214.46 Million CNY | -11.02% |
| 2022 Q3 | 157.8 Million CNY | -18.95% |
| 2022 FY | 721.89 Million CNY | 10.49% |
| 2022 Q4 | 171.52 Million CNY | 8.69% |
| 2022 Q2 | 194.71 Million CNY | -1.58% |
| 2022 Q1 | 197.84 Million CNY | 9.2% |
| 2021 Q4 | 181.17 Million CNY | 9.33% |
| 2021 Q3 | 165.71 Million CNY | -4.05% |
| 2021 Q1 | 133.75 Million CNY | 0.91% |
| 2021 Q2 | 172.71 Million CNY | 29.13% |
| 2021 FY | 653.35 Million CNY | 30.77% |
| 2020 Q2 | 146.56 Million CNY | 57.05% |
| 2020 FY | 499.62 Million CNY | 18.66% |
| 2020 Q4 | 132.54 Million CNY | 4.2% |
| 2020 Q3 | 127.19 Million CNY | -13.21% |
| 2020 Q1 | 93.32 Million CNY | -16.69% |
| 2019 Q3 | 112.02 Million CNY | 13.73% |
| 2019 FY | 421.05 Million CNY | 18.43% |
| 2019 Q4 | 112.02 Million CNY | 0.0% |
| 2019 Q2 | 98.5 Million CNY | 0.0% |
| 2019 Q1 | 98.5 Million CNY | 0.0% |
| 2018 FY | 355.53 Million CNY | 14.46% |
| 2017 FY | 310.6 Million CNY | -7.43% |
| 2016 FY | 335.52 Million CNY | 0.0% |